China Risun Acquisition of Six Hongye Chemicals Enterprises Approved at EGM
Further Leverages the Economics of Scale, Resources and Cost Advantages of these Acquisitions to Strengthen the Leading Position in the Market
HONG KONG, Dec 23, 2020 - (ACN Newswire) - China Risun Group Limited ("China Risun", or the "Group", stock code: 1907), the global leading integrated coke, coking chemical and refined chemical producer and supplier in China, held an Extraordinary General Meeting in Hong Kong and obtained the approval of the acquisition of six Hongye Chemical Enterprises for RMB4.85 billion. Upon completion, the Group can further leverage the economics of scale, resources and cost advantages of these acquisitions to strengthen its leading position in the market.
The Group is committed to continuously explore market opportunities to provide operations management services and expand its business through acquisitions and joint ventures. This transaction is in line with the Group's expansion strategy to capture the potential growth of coke and refined chemicals market and can strengthen the Group's leading position in the market. Given the six Hongye Chemicals Enterprises' production capacity, scale of operation and the market share in their respective regions and considering the Group's expansion plan, the Group believes that the transaction is conducive to the future business expansion of the Company. Moreover, by operating two green factories recognized by the Ministry of Industry and Information Technology of China, the Group can demonstrate through this transaction how to promote industry consolidation and improve coking enterprises by enhancing outdated production facilities. It can further promote the Group's image by taking a leading role in consolidating the standard of environmental protection in the coke industry. It is expected to create synergy with the Group's existing business.
Since July 2019, China Risun has been providing operations management services for the six Hongye Chemicals Enterprises and has been fully responsible for their production, management and operation. The six Hongye Chemicals Enterprises previously were sizable enterprises with a complete industrial chain under the chemical sector of Hongye Group, and they are principally engaged in the production of coke and coking products as well as refined chemicals supply.
After the completion of this transaction, China Risun will be able to expand its geographical reach with the operations and management services business capabilities, and increase the total production of coke and coking products. The Group currently has an annual production capacity of 150,000 tons of caprolactam in its Cangzhou Production Base. The Group's annual production capacity of caprolactam is expected to increase to 350,000 tons by consolidating the annual production capacities of the six Hongye Chemicals Enterprises. (Note: Caprolactam is one of the important organic chemical raw materials. The main purpose is to generate polyamide slice PA6 through polymerization, which can be used in high-end fashion, high-end plastic products, tires, food and drug preservation, outdoor protective equipment, fishery, parachutes, Ropes and other fields). The six Hongye Chemicals Enterprises are based in the Shandong province of China, which is one of the major sales locations of the Group where many of its customers are based. The Group can sell the products manufactured by the six Hongye Chemicals Enterprises to the Group's customers directly from the new production locations which can lower the transportation costs and increase the Group's competitive advantages. Furthermore, the Group can further procure raw materials by economics of scale and enlarge its price spread between its products and its raw materials. This can achieve a higher gross profit margin for the coke products as well as the refined chemical products.
About China Risun Group Limited China Risun Group Limited is the world's largest independent producer and supplier of coke by volume in 2019, according to Frost & Sullivan. China Risun is an integrated coke, coking chemicals and refined chemicals producer and supplier in China and holds leading positions in a number of refined chemicals sectors both in China and globally. The vertically-integrated business model together with more than 25 years of experience in the coal chemicals industry production chain has enabled China Risun to further tap the downstream refined chemicals markets and hence diversify its income sources and create greater value.
China Risun has been listed on the main board of the Hong Kong Stock Exchange since March 2019 and is now included in various index series, including Hang Seng Composite Index, Hang Seng Stock Connect Hong Kong Index, Hang Seng Stock Connect Hong Kong MidCap & SmallCap Index, Hang Seng Stock Connect Hong Kong SmallCap Index, Hang Seng SCHK Mainland China Companies Index, and Hang Seng SCHK ex-AH Companies Index. For more details, please visit http://www.risun.com/En/
Media enquiries Strategic Financial Relations Limited Mandy Go Tel: +852 2864 4812 Email: mandy.go@sprg.com.hk Stephanie Liu Tel: +852 2864 4852 Email: stephanie.liu@sprg.com.hk Carven Tsui Tel: +852 2864 4859 Email: carvensm.tsui@sprg.com.hk Website: http://www.sprg.com.hk
Source: China Risun Group Sectors: Daily Finance, Daily News
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
TOYOTA GAZOO Racing reinforces WRC line-up with youth and experience for 2025 Nov 25, 2024 17:10 JST
| Toyota Submits Progress Report on Recurrence Prevention Measures Nov 25, 2024 15:43 JST
| MHI Thermal Systems Receives Order from Aisan Industry for Aquifer Thermal Energy Storage System for Its New Anjo Plant Nov 25, 2024 14:18 JST
| Oracle Red Bull Racing Driver Max Verstappen Wins Fourth Consecutive F1 Drivers' World Championship Nov 25, 2024 11:55 JST
| Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025 Nov 22, 2024 11:00 JST
| NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth Nov 21, 2024 22:59 JST
| Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan Nov 21, 2024 15:35 JST
| Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP Nov 21, 2024 09:00 JST
| ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study Nov 20, 2024 23:05 JST
| Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center Nov 20, 2024 15:30 JST
| Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Nov 20, 2024 11:51 JST
| Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Nov 20, 2024 10:24 JST
| Kingsoft Announces 2024 Third Quarter Results Nov 19, 2024 18:54 JST
| NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Nov 19, 2024 15:30 JST
| Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings Nov 19, 2024 09:02 JST
| CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report Nov 18, 2024 23:30 JST
| World's First Successful Trial of Quantum Tokens Created Using Quantum Technology Nov 18, 2024 17:29 JST
| Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business Nov 18, 2024 12:31 JST
| Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round Nov 18, 2024 09:25 JST
| COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding Nov 16, 2024 18:00 JST
|
More Latest Release >>
|